Cargando…
ALPPL2 Is a Potential Diagnostic Biomarker for Pancreatic Cancer-Derived Extracellular Vesicles
Pancreatic cancer is an aggressive malignancy that often goes undiagnosed in the early stages. Non-invasive, early, and accurate diagnosis is therefore undoubtedly the “holy grail” of pancreatic cancer research. However, despite extensive research efforts, there is no definitive biomarker for this c...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819892/ https://www.ncbi.nlm.nih.gov/pubmed/31687420 http://dx.doi.org/10.1016/j.omtm.2019.08.016 |